MaryAnn Banerji

1.8k total citations
16 papers, 1.4k citations indexed

About

MaryAnn Banerji is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, MaryAnn Banerji has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in MaryAnn Banerji's work include Adipokines, Inflammation, and Metabolic Diseases (5 papers), Regulation of Appetite and Obesity (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). MaryAnn Banerji is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (5 papers), Regulation of Appetite and Obesity (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). MaryAnn Banerji collaborates with scholars based in United States, Italy and Switzerland. MaryAnn Banerji's co-authors include James R. Sowers, Samy I. McFarlane, Robert E. Ratner, Dawn C. Schwenke, George A. Bray, Ralph A. DeFronzo, Stephen Clement, Robert R. Henry, Nicolas Musi and Devjit Tripathy and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

MaryAnn Banerji

14 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
MaryAnn Banerji United States	12	795	331	311	284	266	16	1.4k
Nele Friedrich Germany	20	885 1.1×	215 0.6×	259 0.8×	256 0.9×	286 1.1×	52	1.6k
Lorenza Santi Italy	14	625 0.8×	332 1.0×	293 0.9×	177 0.6×	187 0.7×	23	1.3k
Christine Massien France	13	563 0.7×	372 1.1×	417 1.3×	459 1.6×	174 0.7×	23	1.6k
Donald A. Bergman United States	15	803 1.0×	299 0.9×	197 0.6×	358 1.3×	459 1.7×	21	1.9k
S.M. Haffner United States	13	606 0.8×	258 0.8×	177 0.6×	237 0.8×	146 0.5×	24	1.2k
Shuhei Nakanishi Japan	26	886 1.1×	607 1.8×	288 0.9×	460 1.6×	473 1.8×	132	1.9k
Ami Laws United States	16	662 0.8×	279 0.8×	206 0.7×	339 1.2×	203 0.8×	21	1.3k
Katherine V. Williams United States	16	1.0k 1.3×	247 0.7×	283 0.9×	422 1.5×	365 1.4×	33	1.8k
Emily Brown United Kingdom	17	686 0.9×	231 0.7×	353 1.1×	191 0.7×	360 1.4×	44	1.3k
Anna Lucas Spain	26	1.0k 1.3×	281 0.8×	175 0.6×	219 0.8×	415 1.6×	57	1.6k

Countries citing papers authored by MaryAnn Banerji

Since Specialization

Citations

This map shows the geographic impact of MaryAnn Banerji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MaryAnn Banerji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MaryAnn Banerji more than expected).

Fields of papers citing papers by MaryAnn Banerji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MaryAnn Banerji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MaryAnn Banerji. The network helps show where MaryAnn Banerji may publish in the future.

Co-authorship network of co-authors of MaryAnn Banerji

This figure shows the co-authorship network connecting the top 25 collaborators of MaryAnn Banerji. A scholar is included among the top collaborators of MaryAnn Banerji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MaryAnn Banerji. MaryAnn Banerji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Alkaissi, Hussam, et al.. (2021). Pachydermoperiostosis: A Rare Masquerader of Acromegaly and Thyroid Acropachy. Journal of the Endocrine Society. 5(Supplement_1). A595–A596.

Banerji, MaryAnn, et al.. (2021). Non-Fasting Hypoglycemia Secondary to Opioid Induced Adrenal Insufficiency: A Case Report. Journal of the Endocrine Society. 5(Supplement_1). A145–A146. 2 indexed citations

Alkaissi, Hussam, et al.. (2021). Pseudohypoglycemia: A Simple Approach to Complex Phenomenon. Journal of the Endocrine Society. 5(Supplement_1). A396–A396.

Jain, Vandana, et al.. (2017). Drugs and hyperglycemia: A practical guide. Maturitas. 104. 80–83. 25 indexed citations

Sharma, Roopali, et al.. (2014). Pheochromocytoma: A review. Maturitas. 77(3). 229–238. 76 indexed citations

Tripathy, Devjit, Stephen Clement, Dawn C. Schwenke, et al.. (2014). Baseline Adiponectin Levels Do Not Influence the Response to Pioglitazone in ACT NOW. Diabetes Care. 37(6). 1706–1711. 13 indexed citations

DeFronzo, Ralph A., Devjit Tripathy, Dawn C. Schwenke, et al.. (2013). Prevention of Diabetes With Pioglitazone in ACT NOW. Diabetes. 62(11). 3920–3926. 85 indexed citations

Saremi, Aramesh, Dawn C. Schwenke, Thomas A. Buchanan, et al.. (2012). Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors. Arteriosclerosis Thrombosis and Vascular Biology. 33(2). 393–399. 85 indexed citations

Gerstein, Hertzel C., Walter T. Ambrosius, Ronald P. Danis, et al.. (2012). Diabetic Retinopathy, Its Progression, and Incident Cardiovascular Events in the ACCORD Trial. Diabetes Care. 36(5). 1266–1271. 76 indexed citations

10.

DeFronzo, Ralph A., MaryAnn Banerji, George A. Bray, et al.. (2009). Actos Now for the prevention of diabetes (ACT NOW) study. BMC Endocrine Disorders. 9(1). 17–17. 64 indexed citations

11.

Misra, Ranjita, Thakor G. Patel, Purushotham Kotha, et al.. (2009). Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study. Journal of Diabetes and its Complications. 24(3). 145–153. 118 indexed citations

12.

Pratley, Richard E., Anja Schweizer, Julio Rosenstock, et al.. (2008). Robust improvements in fasting and prandial measures of β‐cell function with vildagliptin in drug‐naïve patients: analysis of pooled vildagliptin monotherapy database. Diabetes Obesity and Metabolism. 10(10). 931–938. 61 indexed citations

13.

Kaufman, Daniel L., Eric L. Smith, MaryAnn Banerji, et al.. (2005). Early Appearance of the Metabolic Syndrome in Socially Reared Bonnet Macaques. The Journal of Clinical Endocrinology & Metabolism. 90(1). 404–408. 40 indexed citations

14.

McFarlane, Samy I., MaryAnn Banerji, & James R. Sowers. (2001). Insulin Resistance and Cardiovascular Disease1. The Journal of Clinical Endocrinology & Metabolism. 86(2). 713–718. 398 indexed citations

15.

Banerji, MaryAnn. (1999). Body Composition, Visceral Fat, Leptin, and Insulin Resistance in Asian Indian Men. The Journal of Clinical Endocrinology & Metabolism. 84(1). 137–144. 394 indexed citations

16.

Banerji, MaryAnn, et al.. (1999). ANALYSIS OF RISK FACTORS IN TACROLIMUS-ASSOCIATED POST-TRANSPLANT DIABETES (PTDM). ASAIO Journal. 45(2). 176–176. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact